Seller: Grand Eagle Retail, Fairfield, OH, U.S.A.
Hardcover. Condition: new. Hardcover. Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.FeaturesProvides the first book and a single source of information on RWE in drug developmentCovers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD)Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insightsOffers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE is the knowledge derived from aggregation and analysis of RWD. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9780367026219
Quantity: 1 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Hardback. Condition: New. New copy - Usually dispatched within 4 working days. 720. Seller Inventory # B9780367026219
Quantity: 1 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Seller Inventory # 380592427
Quantity: 3 available
Seller: Speedyhen, London, United Kingdom
Condition: NEW. Seller Inventory # NW9780367026219
Quantity: 2 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. Seller Inventory # 26383311604
Quantity: 3 available
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 178 pages. 9.75x6.50x0.75 inches. In Stock. Seller Inventory # __036702621X
Quantity: 1 available
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. 2021. 1st Edition. Hardcover. . . . . . Seller Inventory # V9780367026219
Quantity: 2 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Neuware - This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE is the knowledge derived from aggregation and analysis of RWD. Seller Inventory # 9780367026219
Quantity: 2 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. Seller Inventory # 18383311614
Quantity: 3 available
Seller: moluna, Greven, Germany
Condition: New. Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC pro. Seller Inventory # 395875131
Quantity: 2 available